Jin, Michelle, and James M. Noble.
"What's in It for Me? Contextualizing the Potential Clinical Impacts of Lecanemab, Donanemab, and Other Anti-β-amyloid Monoclonal Antibodies in Early Alzheimer's Disease." eNeuro
11.9
(2024):
ENEURO.0088-24.2024.
Web. 20 April. 2026.
